| Characterization of the myosin adenosine triphosphate (M.ATP) crossbridge in rabbit and frog skeletal muscle fibers Biophysical Journal, Volume 54, Issue 1, 1 July 1988, Pages 135-148 M. Schoenberg Abstract In the presence of ATP and absence of Ca2+, muscle crossbridges have either MgATP or MgADP.Pi bound at the active site (S. B. Marston and R. T. Tregear, Nature [Lond.], 235:22:1972). The behavior of these myosin adenosine triphosphate (M.ATP) crossbridges, both in relaxed skinned rabbit psoas and frog semitendinosus fibers, was analyzed. At very low ionic strength, T = 5 degrees C, mu = 20 mM, these crossbridges spend a large fraction of the time attached to actin. In rabbit, the attachment rate constants at low salt are 10(4) - 10(5) s-1, and the detachment rate constants are approximately 10(4) s-1. When ionic strength is increased up to physiological values by addition of 140 mM potassium propionate, the major effect is a weakening of the crossbridge binding constant approximately 30–40-fold. This effect occurs because of a large decrease, approximately 100-fold, in the crossbridge attachment rate constants. The detachment rate constants decrease only 2–3-fold. The effect of ionic strength on crossbridge binding in the fiber is very similar to the effect of ionic strength on the binding of myosin subfragment-1 to unregulated actin in solution. Thus, the effect of increasing ionic strength in fibers appears to be a direct effect on crossbridge binding rather than an effect on troponin-tropomyosin. The finding that crossbridges with ATP bound at the active site can and do attach to actin over a wide range of ionic strengths strongly suggests that troponin-tropomyosin keeps a muscle relaxed by blocking a step subsequent to crossbridge attachment. Thus, rather than troponin-tropomyosin serving to keep a muscle relaxed by inhibiting attachment, it seems quite possible that the main way in which troponin-tropomyosin regulates muscle activity is by preventing the weakly-binding relaxed crossbridges from going on through the crossbridge cycle into more strongly-binding states. Abstract | PDF (1735 kb) |
| Tropomyosin: Does resolution lead to reconciliation? Current Biology, Volume 4, Issue 7, 1 July 1994, Pages 624-626 M.K. Reedy, M.C. Reedy and F. Schachat Summary New electron microscopic data provide direct evidence in support of the classical steric-blocking model for regulation of actin–myosin interactions by tropomyosin. Summary | Full Text | PDF (411 kb) |
| The influence of doubly attached crossbridges on the mechanical behavior of skeletal muscle fibers under equilibrium conditions Biophysical Journal, Volume 52, Issue 5, 1 November 1987, Pages 901-906 A. Tozeren Abstract A simple model of a double-headed crossbridge is introduced to explain the retardation of force decay after an imposed stretch in skeletal muscle fibers under equilibrium conditions. The critical assumption in the model is that once one of the heads of a crossbridge is attached to one of the available actin sites, the attachment of the second head will be restricted to a level of strain determined by the attachment of the first head. The crossbridge structure, namely the connection of both heads of a crossbridge to the same tail region, is assumed to impose this constraint on the spatial configurations of crossbridge heads. The unique feature of the model is the prediction that, in the presence of a ligand (PPi, ADP, AMP-PNP) and absence of Ca2+, the halftime of force decay is many times larger than the inverse rate of detachment of a crossbridge head measured in solution. This prediction is in agreement with measured values of half-times of force decay in fibers under similar conditions (Schoenberg, M., and E. Eisenberg. 1985. Biophys. J. 48:863–871f). It is predicted that a crossbridge head is more likely to re-attach to its previously strained position than remain unattached while the other head is attached, leading to the slow decay of force. Our computations also show that the apparent cooperativity in crossbridge binding observed in experiments (Brenner, B., L. C. Yu, L. E. Greene, E. Eisenberg, and M. Schoenberg. 1986. Biophys. J. 50:1101–1108) can be partially accounted by the double-headed crossbridge attachment.(ABSTRACT TRUNCATED AT 250 WORDS) Abstract | PDF (603 kb) |
Copyright © 2006 The Biophysical Society. All rights reserved.
Biophysical Journal, Volume 90, Issue 5, 1697-1722, 1 March 2006
doi:10.1529/biophysj.105.069534
Muscle and Contractility
S.A. Niederer
,
, P.J. Hunter and N.P. Smith
Address reprint requests to S. A. Niederer.With each beat, the heart pumps blood around the body. The cyclical activation and relaxation of tension that takes place occurs at the sarcomere spatial scale and is controlled by cellular mechanisms. Each sarcomere is made up of interdigitated protein filaments of actin and myosin. Crossbridges protruding from myosin bind to actin, whereupon they undergo a conformational change, causing the bound crossbridges to pull each filament in opposite directions, producing tension. The process is controlled by both the local free Ca2+ and the intrinsic properties of the sarcomeres themselves.
Contraction is initiated by an increase in local [Ca2+]i. Ca2+ binds to troponin C (TnC) and the resulting shift of tropomyosin reveals the actin binding sites, allowing crossbridges to bind and generate tension. After the removal of [Ca2+]i, bound Ca2+ unbinds from TnC, tropomyosin blocks the actin binding sites, crossbridges detach, and tension returns to zero. The above processes producing the initiation of contraction in cardiac muscle are extensively quantified; however, the equally important mechanisms governing relaxation after contraction are poorly characterized. Thus although the steps are known in the process of relaxation, what controls each step and which step is the most important is unknown.
Relaxation is often quantified by the half-time to relaxation (RT50 the time for tension to decay by 50% from the peak value). RT50 is determined by both the [Ca2+]i transient and the intrinsic properties of the myofilaments. The [Ca2+]i transient influences RT50 when altered pharmacologically 1,2 or by increasing the stimulation frequency 3. The myofilament properties implicated as determinants of RT50 include the tension-dependent binding of Ca2+ to TnC 4, inhomogeneous sarcomere shortening 5, crossbridges inhibiting tropomyosin returning to its resting state 4, phosphorylation of troponin I 6, and sarcomere length (SL) 7. Unraveling the relative influences of each mechanism has proven challenging experimentally. In this study, we address this issue by unifying experimental data into a mathematical model to analyze the significant factors determining relaxation.
Building on the successful approach of cardiac electrophysiology models, cardiac contraction models are now beginning to quantify numerous phenomena, which have previously been poorly defined or only understood and characterized in isolation. Models of cardiac contraction have quantified cooperative mechanisms 8, the effects of contraction in the forward problem of electrocardiography 9, and ventricular pacing on contraction 10, for example. However, the parameters used in active contraction models are often derived from limited sets of experimental results. Here, each parameter was rationalized from numerous sources, and where possible, multiple experimental modalities, through an extensive review of the literature. The sources of each parameter and a brief description of the experimental conditions under which it was obtained are provided in the Tables.
The model is depicted in Fig. 1 and was based on the framework proposed by Hunter et al. 11. The equations and the parameters are described in the following stages:
The model was validated using rapid length-step experiments, caged Ca2+ tension transients, clamped and unclamped SL tension traces, and RT50 as a function of SL.
The ternary cardiac troponin complex (Tn) consists of three subunits: Troponin I, T, and C. TnC contains the regulatory Ca2+ binding site, where the binding of Ca2+ initiates contraction. Troponin I (TnI) inhibits actin-myosin interaction. Troponin T (TnT) plays a structural role binding to TnC, TnI, and Tropomyosin (Tm) 12. TnC consists of N- and C-terminal globular lobes and is connected by a long central helix. The C-terminal contains binding sites III and IV, which bind Ca2+ and magnesium competitively. Under physiological conditions, both sites III and IV are saturated. The N-terminal contains Ca2+specific or low-affinity binding sites I and II. In skeletal TnC, both sites are active; but in cardiac TnC, only site II is active, due to an increased positive charge near site I prohibiting the binding of Ca2+13. In cardiac TnC, site II regulates muscle contraction and is the focus of a large number of studies, due to its potential as a target for Ca2+sensitizing drugs and its fundamental role in excitation-contraction coupling.
Steady-state Ca2+ binding to TnC can be described by a Hill equation with a Hill coefficient of 1 (Eq. (1)) 14. Defining [Ca2+]Trpn as the concentration of Ca2+ bound to TnC site II, [Ca2+]TrpnMax, as the maximum concentration of ions that can bind to site II, [Ca+2]i is the concentration of free Ca2+ and K is the tension-dependent affinity of Ca2+ for TnC. K was determined initially from experimental results with zero or minimal tension (T) and the tension dependence is considered below. [Ca2+]TrpnMax was set to 70μM 15,16:
![]() | (1) |
| Table 1 Binding affinities of Ca2+ to site II of cardiac troponin C |
| Species | Temp (°C) | Troponin complex | Bound Ca2+ measure | Mg (mM) | Kd (M−1) | K (μM) | Ref. | ||
|---|---|---|---|---|---|---|---|---|---|
| Human | 30 | NTnC | NMRs | — | 4×105 | 2.5 | 18 | ||
| Human | 15 | TnC | F27W | None | 4.2×104 | 24 | 25 | ||
| Human | 15 | TnC | F27W | 3 | 1.4×105 | 7.1 | 25 | ||
| Human | 30 | TnC | NMRs | — | 5×104 | 20 | 24 | ||
| Bovine | 4 | TnC | SC | None | 2.5×105 | 4.0 | 13 | ||
| Bovine | 4 | TnC | SC | 4 | 2.5×105 | 4.0 | 13 | ||
| Bovine | — | TnC | IAANS | 3 | 7×105 | 1.4 | 35 | ||
| Bovine | 7 | TnC | F27W | — | 9.3×104 | 11 | 17 | ||
| Bovine | 21 | TnC | F27W | — | 1.9×105 | 5.3 | 17 | ||
| Bovine | 37 | TnC | F27W | — | 2.6×105 | 3.9 | 17 | ||
| Mammal | RT | TnC | IAANS | 3 | 2.5×105 | 4.0 | 23 | ||
| Mammal | RT | TnC | IAANS | None | 4.5×105 | 2.2 | 23 | ||
| Mammal | 21 | TnC | F27W | None | 2×105 | 5.0 | 19 | ||
| Rat | 4 | TnC | IAANS (84) | 3 | 3.2×105 | 3.1 | 20 | ||
| R/B | 23 | TnC | IAANS | 3 | 7.2×105 | 1.4 | 21 | ||
| Chicken | 23 | TnC | IAANS (84) | None | 2.9×105 | 3.5 | 22 | ||
| Chicken | 23 | TnC | IAANS | None | 3.6×105 | 2.8 | 22 | ||
| Chicken | 23 | TnC-TnI | IAANS (84) | 5 | 8×105 | 1.3 | 22 | ||
| Bovine | — | TnC-TnI | IAANS | 3 | 1.5×107 | 0.07 | 35 | ||
| Rat | — | TnC-TnI | IAANS | 3 | 1.7×106 | 0.59 | 26 | ||
| R/B | 23 | TnC-TnI | IAANS | 3 | 1.5×106 | 0.67 | 21 | ||
| Mammal | RT | TnC-TnI | IAANS | None | 3×106 | 0.33 | 23 | ||
| Bovine | 4 | TnC-TnI | SC | 4 | 1×106 | 1.0 | 13 | ||
| Bovine | 4 | TnC-TnI | SC | None | 1×106 | 1.0 | 13 | ||
| Chicken | 23 | Tn | IAANS | 5 | 1.2×106 | 0.83 | 22 | ||
| Bovine | 4 | Tn | SC | None | 2.5×106 | 0.40 | 13 | ||
| Bovine | 4 | Tn | SC | 4 | 2.5×106 | 0.40 | 13 | ||
| Bovine | 25 | Tn-Tm | IAANS | 2.5 | 1.2×106 | 0.83 | 27 | ||
| P/C* | RT | SP | IAANS (84) | 1 | 6.3×105 | 1.6 | 29 | ||
| R/C | RT | SP | IAANS (84) | 1 | 6.3×105 | 1.6 | 29 | ||
| Bovine | 25 | SP | SC | 5 | 4×106† | 0.25 | 33 | ||
| Bovine | 25 | SP | SC | 5 | 2×106† | 0.50 | 32 | ||
| Bovine‡ | 25 | Tn-Tm-A | SC | 2.5 | 4×105 | 2.5 | 27 | ||
| Bovine | 25 | Tn-Tm-A | SC | 2.5 | 9.6×105 | 1.0 | 27 | ||
| Bovine | 25 | Tn-Tm-A | IAANS | 2.5 | 1.1×106 | 0.91 | 27 | ||
| Bovine | 25 | SP | SC | 5 | 2×106† | 0.5 | 34 | ||
| R/C | 23 | SP | IAANS | 1 | 2×105 | 0.5 | 22 | ||
| R/C | 23 | SP | IAANS (84) | 1 | 4.7×105 | 2.1 | 22 | ||
| Canine | 25 | SP | SC | 2, 10 | 1.2×106 | 0.83 | 28 | ||
| Canine | 25 | SP | SC | 2 | 2.36×105 | 4.2 | 31 | ||
| IAANS is IAANS-labeled TnC; IAANS (84) is IAANS-labeled TnC, with Cys amino acids at residue 84; NMRs is NMR spectroscopy; None=<1×10–3mM; P/C is porcine fiber with chicken TnC; R/B is rat fiber/bovine Tn-Tm; R/C is rat fiber with chicken TnC; SC is scintillation counting; and SP is skinned preparation. RT is room temperature. |
| * BDM added. † Affinity for sites II, III, and IV combined. ‡ IAANS bound, but not used to measure affinity. |
Equation (2) defines the kinetic binding of Ca2+ to site II in TnC was proposed by Robertson et al. 14. The value kon is the rate of binding and koff is the tension-dependent rate of unbinding of Ca2+ from TnC. Equation (1) is the steady-state solution to Eq. (2) with K=koff/kon:
![]() | (2) |
| Table 2 Binding and unbinding rates of Ca2+ to site II in TnC |
| Species | Muscle | Temp (°C) | Troponin complex | Bound Ca2+ measure | Kon (μM−1 s−1) | Koff (s−1) | Ref. | ||
|---|---|---|---|---|---|---|---|---|---|
| Rabbit | S | 4 | TnC | F29W | 100–200 | — | 50 | ||
| Rabbit | S | 4 | TnC | DANZ | 100–200 | — | 50 | ||
| Rabbit | S | 15 | TnC | F29W | 100 | 340 | 51 | ||
| Rabbit | S | 22 | TnC | F29W | — | 350 | 50 | ||
| Rabbit | S | 22 | TnC | DANZ | — | 551 | 50 | ||
| Rabbit | S | 22 | TnC | Quin-2 | 290 | 462 | 50 | ||
| Human | C | 4 | TnC | IAANS | — | 73 | 52 | ||
| Human | C | 15 | TnC | F27W | 170 | 1159–1263 | 25 | ||
| Human | C | 20 | TnC | IAANS | 100 | 483 | 52 | ||
| Human | C | 30 | TnC | NMRs | 250 | 5000 | 24 | ||
| Bovine | C | 4 | TnC | IAANS | 51 | 11 | 48 | ||
| Bovine | C | 15 | TnC | Quin-2 | — | 136.5 | 49 | ||
| Chicken | C | 4 | TnC | Quin-2, BAPTA | 200–400 | 700–800 | 53 | ||
| Rat | C | 4 | TnC | IAANS | 140 | 437 | 20 | ||
| Bovine | C | 4 | TnC-TnI | IAANS | 59 | 12 | 48 | ||
| Bovine | C | 15 | Tn-Tm | IANDB | — | 16.2–18.2 | 49 | ||
| Bovine | C | 15 | Tn-Tm | Quin-2 | — | 23 | 49 | ||
| Chicken | S | 4 | Tn-Tm | IANDB | 10 | 1.3 | 47 | ||
| Chicken | S | 20 | Tn-Tm | IANDB | 65 | 13 | 47 | ||
| Model | C | N/A | SP | — | 39 | 19.6 | 14 | ||
| C is cardiac; S is skeletal. |
The tension-dependent binding of Ca2+ to TnC has been elucidated via a number of discrete experimental techniques. The affinity of Ca2+ for TnC decreases during rapid step-length reduction experiments on intact muscle 55,56,57. The concentration of Ca2+ bound to TnC decreases when tension development is inhibited with vanadium 33,40. Modeling experiments using Ca2+-sensitizing drugs indicate that Ca2+ binding to TnC is likely to be tension-dependent 58. The tension-dependent unbinding rate from Eq. (2) is defined by Eq. (3), below. The form of Eq. (3) captures tension-dependent components of Ca2+ binding to site II of TnC as well as the length-dependent components, as discussed below.
![]() | (3) |
Fuchs and co-workers have shown that the concentration of bound Ca2+ is both tension- 33,40,44 and length-dependent 32,38,40,42,44 in skinned preparations. However, it is likely that these two dependencies are related by the number of attached crossbridges 55, which increases with length 59 and has been shown to increase the binding affinity of Ca2+ for TnC 47. The tension dependence of Ca2+ binding to TnC is consistently supported by the results within individual experiments. Comparing results between experiments, however, reveals inconsistencies. In the absence of bound crossbridges due to the addition of vanadate, between ≈75% 33,40 and ≈50% 44 of site IIs are occupied at pCa=5. It was then expected that, if tension were the only factor determining the binding of Ca2+ to TnC, then at pCa=5, no less than 50–75% of sites should be occupied in the presence of tension, yet measurements of 35% 32, 49% 44, and 69% 42 of site IIs occupied at pCa 5 in the presence of tension have been reported. The variation can be rationalized by three potential mechanisms. Firstly, that some mechanism other than bound crossbridges affects affinity. Secondly, variations between preparations affected the results. Thirdly, the method used here to calculate the number of ions bound to site II introduces or increases variation in the measurements. Fuchs and co-workers measured the total concentration of Ca2+ bound to all three sites of TnC. As sites III and IV are known to have a higher affinity than site II it was assumed that they are both saturated at pCa 5. Therefore the fraction of site IIs occupied by Ca2+ is equal to the total number of ions bound per TnC molecule less two. As a result, the fraction of site IIs occupied by Ca2+ is sensitive to experimental noise. If, on average, a total of 2.8 ions are bound to TnC at pCa=5, then a variation of 3.6% 32 in the total number of ions bound to TnC corresponds to a variation of 0.1 ions. Subtracting the two ions bound to the saturated sites III and IV from the total number of ions bound (2.8 ions) means that there is a 0.1 ion variation in the remaining 0.8 ions bound to site II, which corresponds to a 12.5% variation in the number of ions bound to site II. This amplification of the experimental noise potentially explains the variation in experimental results observed. The affinity of Ca2+ for TnC in the absence of tension derived from Table 1 was 2μM, which corresponds to 83% of site IIs being occupied at pCa 5 in the absence of tension, comparable with measurements of ≈75% 33,40. The value γ was determined using the K-value in the absence of tension defined above and a subset of results from Table 3. Results from experiments where Dextran or Vanadate were added, when the average SL was outside the physiological range of 1.8–2.3μm or when the fraction of bound Ca2+ is <83% at pCa 5 (the value defined by Eq. (1) at zero tension), were excluded from the subset. The final subset took results from Fuchs and co-workers 32,33,38,42,44; γ was determined for each measurement, and the average γ-value was 1.9.
| Table 3 Ca2+ bound to bovine cardiac troponin C site II |
| Temp (°C) | Additives | Sarcomere length (μm) | Fraction of site II with bound Ca2+ | Ref. | ||
|---|---|---|---|---|---|---|
| 22 | None | 1.5–1.6 | 0.49 | 44 | ||
| 22 | None | 1.7 | 0.83 | 38 | ||
| — | None | 1.7 | 0.69 | 42 | ||
| RT | None | 1.74 | 0.25 | 40 | ||
| 25 | None | 1.81 | 0.35 | 32 | ||
| 22 | None | 1.9 | 0.80 | 43 | ||
| 22 | None | 2.2–2.3 | 1 | 44 | ||
| 22 | None | 2.2–2.3 | 1 | 44 | ||
| 22 | None | 2.3 | 1 | 38 | ||
| — | None | 2.3 | 0.94 | 42 | ||
| 25 | None | 2.34 | 1 | 32 | ||
| 25 | None | 2–2.5 | 1 | 33 | ||
| RT | None | 2.45 | 1 | 42 | ||
| 22 | 2% dextran | 2 | 1 | 38 | ||
| 22 | 5% dextran | 1.7 | 1 | 38 | ||
| — | 5% dextran | 1.7 | 1.0 | 42 | ||
| — | 5% dextran | 2.3 | 1.0 | 42 | ||
| 22 | 5% dextran | 1.9 | 1.0 | 43 | ||
| 22 | 10% dextran | 1.9 | 0.80 | 43 | ||
| 22 | 15% dextran | 1.9 | 0.26 | 43 | ||
| 25 | 1mM Vi | 2–2.5 | 0.74 | 33 | ||
| RT | 1mM Vi | 2.28–2.34 | 0.72 | 40 | ||
| RT | 1mM Vi | 1.52–1.78 | 0.72 | 40 | ||
| 22 | 1mM Vi | 2.2–2.3 | 0.50 | 44 | ||
| RT is room temperature. Bound calcium is calculated using 0.34μmol troponin/g of fiber. Bovine cardiac muscle at pCa5 is used in all cases. It is assumed that, at pCa 5.0, the high-affinity sites are saturated. If total calculated bound Ca2+ was >3, it is assumed that site II is saturated. It is assumed T ≈T0 at pCa5, in the absence of any additives. |
To ensure that the skinning procedure did not affect the tension dependence of K, skinned results were compared with intact values. In intact preparations, length-step experiments elucidate the value of γ. Results by Allen and Kentish 56, using the Ca2+ released during length step experiments, estimated that the affinity of Ca2+ for TnC (K) would halve when tension was dropped to zero during a length step corresponding to a γ-value of 2. Komukai et al. 57 found a linear relationship between Δ[Ca+2]i/[Ca+2]i (the ratio of the quantity of Ca2+ released during a step change to the free Ca2+ before a length change) with the tension before by the length change (T1) as tension increased (see Eq. (4)). The size of the length steps were defined such that the tension after the length change was equal to zero:
![]() | (4) |
![]() | (5) |
![]() | (6) |
![]() | (7) |
![]() | (8) |
The Ca2+ affinity for TnC has also been shown to vary with SL32,40,44. In length-step experiments, the affinity of TnC drops significantly but the SL remains largely unchanged. The γ -value required to capture this phenomenon is close to the γ-value required to model the change in calcium affinity at varying fixed SL values. Hence, the SL dependence of the affinity is accounted for by the tension dependence, as maximum tension and tension-based Ca2+ sensitivity increase with increasing SL (discussed below). This hypothesis coincides with experiments, where crossbridge heads (myosin subfragment 1) bound to actin in the absence of myosin or any reference length increased the binding affinity of Ca2+ for TnC 47. In the model, the length dependence is accounted for by the tension dependence and the form of the equation is validated by Komukai’s results. Considering these results γ will be set to 2.
Tropomyosin is a highly extended α-helical coil situated in the actin groove, with each tropomyosin molecule spanning seven actin monomers 27. When tropomyosin is shifted out of the actin groove, the steric hindrance preventing actin binding to myosin is removed, allowing tension to develop. In the model, tropomyosin was characterized by z, the fraction of actin sites available for crossbridge binding. In this study, it is assumed that crossbridges bind rapidly relative to thin filament kinetics and that not all actin sites are available at full activation. Thus, tension is proportional to z and the ratio of z to the fraction of actin sites available at full activation for a given SL (z/zMax) is equal to the ratio of the isometric tension to the maximum tension at full activation for the same SL (T0/T0Max). The value z is defined by Eq. (9), below. The fraction of actin sites available at full activation (zMax) is defined by Eq. (14), the steady-state solution to Eq. (9) at full activation ([Ca2+]Trpn=[Ca2+]TrpnMax). The value T0 is the isometric tension at a given [Ca2+]i and SL (see Eq. (16)). The value T0Max is the isometric tension at full activation for a given SL (see Eq. (15)).
![]() | (9) |
Tropomyosin kinetics are described in four stages, which were cyclically iterated through. Briefly, first, the relaxation parameters (αr1, αr2, Kz, and nr) are defined using step changes in Ca2+ experiments. Secondly, length-dependent activation ([Ca2+]Trpn50) is defined using half-activation values from skinned preparations and the resulting equation is scaled to match intact preparation data. Thirdly, α0 and n are defined for skinned and intact preparations by fitting the steady-state solution of Eq. (9) to the respective F-pCa curves. Finally, zMax—the fraction of actin sites available at maximum activation—is calculated using the steady-state solution to Eq. (9).
The relaxation kinetics described by Eq. (9) propose two stages for relaxation, as seen experimentally. It was found that a linear component involving αr1 characterized the slow process and a nonlinear component in the form of a Hill relation was required to model the fast component. Using the combined linear and nonlinear off-rates, the biphasic nature of relaxation was captured. To compare model simulations with experimental results, the relative tension T0/T0Max (or equivalently, T/T0 in experimental nomenclature) was calculated using T0/T0Max= z/zMax, where zMax is defined below by Eq. (14).
The relaxation components of Eq. (9) were fitted using the tension transient after a step decrease in free Ca2+ using the light-activated Ca2+ chelator diazo-2. Ca2+ disassociates rapidly from TnC after a step decrease in
and was therefore expected to have a minimal affect, such that the relaxation kinetics of tropomyosin solely determine the tension transient. In Ca2+ step experiments the muscle is often removed from the bathing solution and exposed to a pulse of light, which greatly increases the affinity of diazo-2 for Ca2+, causing a reduction of free Ca2+ on a millisecond timescale. Data from rat and guinea pig preparations were used with both similarities and dissimilarities between species being observed. Experiments are commonly performed in air at the due temperature to reduce the affects of evaporation or condensation. As such, most experiments are performed at 12–15°C with the exception of results from Kentish and Palmer 63,66, where the muscle was kept in the bathing solution at 20–22°C. Results from diazo-2 experiments are summarized in Table 4. A biphasic tension transient is observed in most experiments, which is fitted with two exponentials. The rates are ≈10–12s−1 and ≈2–4s−1, respectively, at 12–15°C for rat and guinea pig 60,62,64,65; and ≈16–18s−1 and ≈1s−1 at 22°C for rat in two other studies, respectively 63,66. The sole anomaly was recorded by Saeki et al. 61, who reported a fast transient of 73.5s−1, six times larger than any other experiment. The subsequent article by the same group using similar methods did not record the higher transient rate, and made no reference to their earlier results 60. The tension transients recorded by Simnett et al. 65 at 20°C had a half-time to relaxation of 53.4ms, approximately the same as the control rat measurements at 15°C from Fitzimons et al. 62, which had a half-time to relaxation of 64.5ms. However, removing the muscle from the bath would result in a drop in temperature of 2–3°C 65, and during activation, ADP and Pi can build up in preparations removed from the bath 63, both of which would affect relaxation. Palmer and Kentish 63,66 recorded relaxation times using rat trabeculae contained in the bathing solution, reducing any buildup of Pi or ADP and attaining data at 22°C, but characteristic tension traces published by Palmer and Kentish had a maximum tension of ≈0.3 T0. The relaxation parameters were chosen to fit experimental results from Saeki et al. 60 and Simnett et al. 65 at 12–15°C, since an accurate fit to all data was not possible with limited information on SL6,64, relative amplitudes of fast and slow processes 62,66, and initial tension 63. Fig. 3 shows results from Saeki et al. 60 (points) and model simulations (lines) with αr1, αr2, Kz, and nr equal to 2s−1, 1.75s−1, 0.15, and 3, respectively.